NasdaqCM - Delayed Quote
USD
Instil Bio, Inc. (TIL)
6.83
-0.16
(-2.29%)
At close: November 6 at 4:00:01 PM EST
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Bronson Crouch
|
Chairman & CEO | 1.18M | -- | 1973 |
|
Dr. Sandeep Laumas M.D.
|
CFO & Chief Business Officer | 775.56k | -- | 1969 |
Instil Bio, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 17
Description
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Corporate Governance
Instil Bio, Inc.’s ISS Governance QualityScore as of November 1, 2026 is 9. The pillar scores are Audit: 6; Board: 8; Shareholder Rights: 8; Compensation: 9.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
